Skip to content
Hair Pipeline
← Back to the pipeline

OMA102

An undisclosed EMS candidate at phase 3 in female pattern baldness.

Phase 3OtherUndisclosed

No public activity in over 18 months

Developed by
EMS
Current phase
Phase 3

Large confirmatory trials. The last step before filing.

Indications
Female pattern hair loss
Last public activity
February 2024
Record confidence
Low

Why it matters

The second Brazilian phase 3 in female pattern hair loss in this register, from a different sponsor. Two independent registrational programmes in one country and one indication is a signal about where this field is actually being developed, whatever either compound turns out to be.

Development history

  1. Phase 3

    First Phase 3 trial on record: NCT05824065 — Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss

    ClinicalTrials.gov ↗

Registered trials

Pulled automatically from ClinicalTrials.gov. Matching is by name and development code, so occasional gaps are possible — tell us if you spot one.

  • NCT05824065Phase 3NOT YET RECRUITING

    Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss

    EMS · n=504 · January 2025

Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first.

Sources